Back to Search
THOMAS KORFHAGEN, M.D.
M.D.
Pediatrics Physician
NPI: 1952332116Individual
Specialties, Licenses & Credentials
Pediatrics PhysicianPrimary
Pediatrics
Code: 208000000X
35-04-8874(OH)
Clinical Genetics (M.D.) Physician
Medical Genetics — Clinical Genetics (M.D.)
Code: 207SG0201X
35.048874(OH)
Research & Publications (20)
Rapamycin prevents transforming growth factor-alpha-induced pulmonary fibrosis.
PMID 19244201·Am J Respir Cell Mol Biol·2009
7-preclinical
Surfactant protein A (SP-A)-mediated bacterial clearance: SP-A and cystic fibrosis.
PMID 11726390·Am J Respir Cell Mol Biol·2001
8-other
Surfactant-associated protein B is critical to survival in nickel-induced injury in mice.
PMID 19131640·Am J Respir Cell Mol Biol·2009
7-preclinical
Surfactant protein-D regulates the postnatal maturation of pulmonary surfactant lipid pool sizes.
PMID 19265061·J Appl Physiol (1985)·2009
7-preclinical
Matrix metalloproteinase-14 mediates a phenotypic shift in the airways to increase mucin production.
PMID 19661247·Am J Respir Crit Care Med·2009
7-preclinical
Early growth response-1 suppresses epidermal growth factor receptor-mediated airway hyperresponsiveness and lung remodeling in mice.
PMID 19188657·Am J Respir Cell Mol Biol·2009
7-preclinical
Surfactant protein C-deficient mice are susceptible to respiratory syncytial virus infection.
PMID 19304906·Am J Physiol Lung Cell Mol Physiol·2009
7-preclinical
EGF receptor tyrosine kinase inhibitors diminish transforming growth factor-alpha-induced pulmonary fibrosis.
PMID 18424623·Am J Physiol Lung Cell Mol Physiol·2008
7-preclinical
Macrophage dysfunction and susceptibility to pulmonary Pseudomonas aeruginosa infection in surfactant protein C-deficient mice.
PMID 18566429·J Immunol·2008
7-preclinical
Acrolein-activated matrix metalloproteinase 9 contributes to persistent mucin production.
PMID 18006877·Am J Respir Cell Mol Biol·2008
7-preclinical
Genomic profile of matrix and vasculature remodeling in TGF-alpha induced pulmonary fibrosis.
PMID 17496152·Am J Respir Cell Mol Biol·2007
7-preclinical
Perinatal increases in TGF-{alpha} disrupt the saccular phase of lung morphogenesis and cause remodeling: microarray analysis.
PMID 17468132·Am J Physiol Lung Cell Mol Physiol·2007
7-preclinical
Surfactant protein-D and surfactant inhibit endotoxin-induced pulmonary inflammation.
PMID 17925426·Chest·2007
7-preclinical
SPDEF regulates goblet cell hyperplasia in the airway epithelium.
PMID 17347682·J Clin Invest·2007
7-preclinical
GM-CSF regulates a PU.1-dependent transcriptional program determining the pulmonary response to LPS.
PMID 16917076·Am J Respir Cell Mol Biol·2007
7-preclinical
Surfactant protein D regulates the cell surface expression of alveolar macrophage beta(2)-integrins.
PMID 17056703·Am J Physiol Lung Cell Mol Physiol·2007
7-preclinical
Neither SP-A nor NH2-terminal domains of SP-A can substitute for SP-D in regulation of alveolar homeostasis.
PMID 16500946·Am J Physiol Lung Cell Mol Physiol·2006
7-preclinical
Surfactant protein-D regulates soluble CD14 through matrix metalloproteinase-12.
PMID 15814723·J Immunol·2005
7-preclinical
Increased susceptibility of purinergic receptor-deficient mice to lung infection with Pseudomonas aeruginosa.
PMID 16024720·Am J Physiol Lung Cell Mol Physiol·2005
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3333 BURNET AVE, ML 7009
CINCINNATI, OH 45229 - Phone
- (513) 636-4830
Quick Facts
- NPI
- 1952332116
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile